The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
Low-dose Naltrexone: An Alternative Treatment for Erythrodermic Psoriasis
Cureus
24 January 2019
https://www.cureus.com/articles/10833-low-dose-naltrexone-an-alternative-treatment-for-erythrodermic-psoriasis
In vitro evaluation of Naltrexone HCl 1% Topical Cream in XemaTop™ for psoriasis
Arch Dermatol Res
March 2020
https://pubmed.ncbi.nlm.nih.gov/31667579/
Naltrexone Hydrochloride 1.5-mg and 4.5-mg Capsules
US Pharm
19 March 2020
https://www.uspharmacist.com/article/naltrexone-hydrochloride-15mg-and-45mg-capsules
Bernard Bihari, MD: Low-Dose Naltrexone for normalizing immune system function
Altern Ther Health Med
05 November 2013
http://todayspractitioner.com/wp-content/uploads/2013/10/Bernard-Bihari-MD-Low-dose-Naltrexone-for-Normalizing-Immune-System-Function-athm_19_2_bihari_56_65.pdf
Low-dose Naltrexone Therapy for Psoriasis
Int J Pharm Compd
Mar-Apr 2020
https://pubmed.ncbi.nlm.nih.gov/32196470/
Efficacy of Low Dose Naltrexone in Psoriasis
J Coll Physicians Surg Pak
June 2020
https://pubmed.ncbi.nlm.nih.gov/32703340/
Objective: To determine the efficacy of low dose naltrexone in the patients of psoriasis.
Study design: Non-randomised clinical trial.
Place and duration of study: Department of Dermatology, Jinnah Postgraduate Medical Centre, Karachi from January to July 2019.
Deanna Windham, DO - Psoriasis: A Novel Approach to Treatment (2017 Conference) (LDN, low dose naltrexone)
In this presentation, Dr Windham speaks about the patients in her practice and how her wealth of experience has helped her to be able to treat newer patients with greater efficacy. She also mentions the rapidly changing scientific outlook on Psoriasis, emphasising the importance of new research.
Laurie Marzell, ND - LDN Case Studies (2017 Conference) (LDN, low dose naltrexone)